GSK Statistics
Share Statistics
GSK has 4.05B
shares outstanding. The number of shares has increased by -0.25%
in one year.
| Shares Outstanding | 4.05B |
| Shares Change (YoY) | -0.25% |
| Shares Change (QoQ) | -0.31% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 1.14M, so 0.03% of the outstanding
shares have been sold short.
| Short Interest | 1.14M |
| Short % of Shares Out | 0.03% |
| Short % of Float | 0.03% |
| Short Ratio (days to cover) | 266.95 |
Valuation Ratios
The PE ratio is 21.31 and the forward
PE ratio is null.
GSK's PEG ratio is
-0.45.
| PE Ratio | 21.31 |
| Forward PE | n/a |
| PS Ratio | 1.75 |
| Forward PS | n/a |
| PB Ratio | 4.01 |
| P/FCF Ratio | 15.36 |
| PEG Ratio | -0.45 |
Financial Ratio HistoryEnterprise Valuation
GSK has an Enterprise Value (EV) of 68.16B.
| EV / Sales | 2.17 |
| EV / EBITDA | 10.22 |
| EV / EBIT | 10.4 |
| EV / FCF | 19.08 |
Financial Position
The company has a current ratio of 0.78,
with a Debt / Equity ratio of 1.24.
| Current Ratio | 0.78 |
| Quick Ratio | 0.52 |
| Debt / Equity | 1.24 |
| Debt / EBITDA | 2.55 |
| Debt / FCF | 4.76 |
| Interest Coverage | 6.28 |
Financial Efficiency
Return on Equity is 18.84% and Return on Invested Capital is 8.51%.
| Return on Equity | 18.84% |
| Return on Assets | 4.33% |
| Return on Invested Capital | 8.51% |
| Revenue Per Employee | $457,182.82 |
| Profits Per Employee | $37,520.58 |
| Employee Count | 68,629 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 1.6 |
Taxes
| Income Tax | 526M |
| Effective Tax Rate | 15.13% |
Stock Price Statistics
The stock price has increased by -20.95% in the
last 52 weeks. The beta is 0.27, so GSK's
price volatility has been higher than the market average.
| Beta | 0.27 |
| 52-Week Price Change | -20.95% |
| 50-Day Moving Average | 18.7 |
| 200-Day Moving Average | 18.65 |
| Relative Strength Index (RSI) | 46.28 |
| Average Volume (20 Days) | 2,477 |
Income Statement
In the last 12 months, GSK had revenue of 31.38B
and earned 2.58B
in profits. Earnings per share was 0.63.
| Revenue | 31.38B |
| Gross Profit | 22.33B |
| Operating Income | 4.02B |
| Net Income | 2.58B |
| EBITDA | 6.67B |
| EBIT | 4.12B |
| Earnings Per Share (EPS) | 0.63 |
Full Income StatementBalance Sheet
The company has 3.69B in cash and 16.99B in
debt, giving a net cash position of -13.29B.
| Cash & Cash Equivalents | 3.69B |
| Total Debt | 16.99B |
| Net Cash | -13.29B |
| Retained Earnings | 7.8B |
| Total Assets | 60.7B |
| Working Capital | -2.75B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 6.55B
and capital expenditures -2.98B, giving a free cash flow of 3.57B.
| Operating Cash Flow | 6.55B |
| Capital Expenditures | -2.98B |
| Free Cash Flow | 3.57B |
| FCF Per Share | 0.88 |
Full Cash Flow StatementMargins
Gross margin is 71.16%, with operating and profit margins of 12.82% and 8.21%.
| Gross Margin | 71.16% |
| Operating Margin | 12.82% |
| Pretax Margin | 11.08% |
| Profit Margin | 8.21% |
| EBITDA Margin | 21.25% |
| EBIT Margin | 12.82% |
| FCF Margin | 11.38% |
